Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major
- 7 January 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (4), e1015-e1024
- https://doi.org/10.1210/clinem/dgz309
Abstract
Objective To identify major mineral and hormonal factors related to BMD in adult TM patients to provide human evidence for the proposed mechanisms. Design Retrospective study. Setting Referral center. Patients Twenty-nine patients with β-TM, aged 23-44 years, who were followed-up during 2017 to 2018 were enrolled. Outcome measurements Endocrine profiles, including thyroid, parathyroid, and pituitary function, glucose, vitamin D, calcium, phosphate, and fibroblast growth factor 23 (FGF23) were obtained. The relationships among the above parameters, body height, fractures, and BMD were analyzed. Results Abnormal BMD was observed in 42.9% of women and 23.1% of men. The mean final heights of women and men were 3.7 cm and 7.3 cm lower than the mean expected values, respectively. Fracture history was recorded in 26.7% of women and 35.7% of men. BMD was negatively correlated with parathyroid hormone, FGF23, thyrotropin, and glycated hemoglobin (HbA1c) levels, and positively correlated with testosterone, IGF-1, and corticotropin levels (all p<0.05). Moreover, hypothyroidism was associated with lower BMD in both the lumbar spine (p=0.024) and the femoral neck (p=0.004). Patients with hypothyroidism had a higher percentage of abnormal BMD (p=0.016). Conclusion Hypothyroidism, higher HbA1c, and lower ACTH were predictors of abnormal BMD in patients with β-TM. Whether the correction of these factors improves BMD warrants further research.Keywords
Funding Information
- Liver Disease Prevention and Treatment Research Foundation
- National Taiwan University Hospital
- National Taiwan University
- Wong-Yuan Endocrine Fund
This publication has 33 references indexed in Scilit:
- Individualized fracture risk assessmentCurrent Opinion in Rheumatology, 2013
- Vitamin D Deficiency in Adults: When to Test and How to TreatMayo Clinic Proceedings, 2010
- Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG‐63 cellsCell Biochemistry and Function, 2010
- ACTH protects against glucocorticoid-induced osteonecrosis of boneProceedings of the National Academy of Sciences of the United States of America, 2010
- FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective StudyJournal of Clinical Endocrinology & Metabolism, 2009
- Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemiaBone, 2008
- Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In VitroJournal of Bone and Mineral Research, 2008
- Prevalence of fractures among the Thalassemia syndromes in North AmericaBone, 2006
- Fibroblast Growth Factor-23 in Patients with Graves’ Disease before and after Antithyroid Therapy: Its Important Role in Serum Phosphate RegulationJournal of Clinical Endocrinology & Metabolism, 2005
- New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemiaBritish Journal of Haematology, 2004